Moreover, as CYLD can be transcriptionally induced by the NF-κB pathway in a negative feedback pathway [47], we may have uncovered a mechanism that leads to persistent NF-κB activation in gastric cancer. The gene discussed is NFKB1; the disease is gastric cancer.